Retinoids in mammary cancer

Using the MNU mammary tumor system. Moon et al. (1983a) have evaluated a number of synthetic retinoids for prevention of mammary cancer (Table II). All the active compounds listed in Table II are highly effective in reducing the incidence and number of mammary cancers. 4-Hydroxyphenylretinamide (4-HPR) (El6) is the most efficacious synthetic retinoid in mammary cancer prevention when both chemopreventive activity and toxicity are taken into consideration. 

---

See also in sourсe #XX -- [ ]

See also in sourсe #XX -- [ ]

See also in sourсe #XX -- [ , ]

---